Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Coho

LUND, Sweden, Jan. 18, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going OPTIMIZE-1 clinical Phase Ib/II trial with the company's

Related Keywords

Sweden , France , Belgium , Julie Silber , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Macrogenics Inc , Orion Corporation , Biotheus Inc , Nasdaq Stockholm , Shanghai Henlius Biotech , Alligator Bioscience , Press Release , Alligator , Ioscience , Nnounces , Optimize , Trial , Update , Cohort , Bully , Hosed , Madverse , Effects , Eported ,